Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary.

European journal of preventive cardiology - 11 Nov 2024

Gu Jing, Gupta Rupal N, Cheng Henry K, Xu Yingxin, Raal Frederick J

Abstract excerpt

AIMS: Homozygous familial hypercholesterolaemia (HoFH) is a rare disorder characterized by markedly elevated circulating low-density lipoprotein cholesterol (LDL-C) from birth. This review aimed to critically evaluate treatments for HoFH with respect to their efficacy, safety, accessibility, overall context and position within the treatment pathway. METHODS AND RESULTS: A mixed-methods review was undertaken to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Component Removal

Share to Cholesterol, LDL

Share to Homozygote

Share to Hyperlipoproteinemia Type II

Share to Proprotein Convertase 9

Share to Treatment Outcome

Source

Identifiers

PMID: 38640433
DOI: 10.1093/eurjpc/zwae144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary.PMID 38640433Read ↗

Evidence for improved survival with treatment of homozygous familial hypercholesterolemiaSemantic proximity Read ↗

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.Semantic proximity Read ↗

Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.Semantic proximity Read ↗

From physiopathology to treatment of familial hypercholesterolemia: Existing and emerging pharmacotherapies.Semantic proximity Read ↗

Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors.Semantic proximity Read ↗

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Semantic proximity Read ↗

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.Semantic proximity Read ↗

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives.Semantic proximity Read ↗

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.Semantic proximity Read ↗

New treatments on the horizon for familial hypercholesterolemia.Semantic proximity Read ↗

Management of homozygous familial hypercholesterolaemia in two brothers.Semantic proximity Read ↗

Optimal management of familial hypercholesterolemia: treatment and management strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.